275 related articles for article (PubMed ID: 30734495)
1. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.
Masuda T; Nakashima T; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
J Cell Mol Med; 2019 Apr; 23(4):2984-2994. PubMed ID: 30734495
[TBL] [Abstract][Full Text] [Related]
2. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.
Che Y; Wang J; Li Y; Lu Z; Huang J; Sun S; Mao S; Lei Y; Zang R; Sun N; He J
Cell Death Dis; 2018 Jul; 9(7):759. PubMed ID: 29988148
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer.
Zhang Y; Bian Y; Wang Y; Wang Y; Duan X; Han Y; Zhang L; Wang F; Gu Z; Qin Z
J Cell Mol Med; 2021 Jun; 25(12):5457-5469. PubMed ID: 33943003
[TBL] [Abstract][Full Text] [Related]
5. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population.
Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M
Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of combining immunohistochemical markers for cancer-associated fibroblasts in lung adenocarcinoma tissue.
Inoue C; Tamatsuki D; Miki Y; Saito R; Okada Y; Sasano H
Virchows Arch; 2019 Aug; 475(2):181-189. PubMed ID: 31134329
[TBL] [Abstract][Full Text] [Related]
9. CD66b
Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-1 promotes the transcriptional activation of plasminogen activator inhibitor type 1 in carcinoma-associated fibroblasts.
Zhu Y; Yin WL; Ba YF; Tian L; Gu ZQ; Zhang MS; Zhong CN
Mol Med Rep; 2012 Nov; 6(5):1001-5. PubMed ID: 22895748
[TBL] [Abstract][Full Text] [Related]
11. [SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549
by Supressing Stat3-EMT via CAFs Exosomes].
Wang S; Cui J; Zhang K; Gu J; Zheng Y; Zhang B; Shi L
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):384-393. PubMed ID: 34024061
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
13. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells.
Li Y; Chen Y; Miao L; Wang Y; Yu M; Yan X; Zhao Q; Cai H; Xiao Y; Huang G
Cancer Lett; 2021 Jan; 497():212-220. PubMed ID: 33132120
[TBL] [Abstract][Full Text] [Related]
14. Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition.
Tang PC; Chung JY; Xue VW; Xiao J; Meng XM; Huang XR; Zhou S; Chan AS; Tsang AC; Cheng AS; Lee TL; Leung KT; Lam EW; To KF; Tang PM; Lan HY
Adv Sci (Weinh); 2022 Jan; 9(1):e2101235. PubMed ID: 34791825
[TBL] [Abstract][Full Text] [Related]
15. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.
Hanley CJ; Mellone M; Ford K; Thirdborough SM; Mellows T; Frampton SJ; Smith DM; Harden E; Szyndralewiez C; Bullock M; Noble F; Moutasim KA; King EV; Vijayanand P; Mirnezami AH; Underwood TJ; Ottensmeier CH; Thomas GJ
J Natl Cancer Inst; 2018 Jan; 110(1):109-20. PubMed ID: 28922779
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.
Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y
Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
[TBL] [Abstract][Full Text] [Related]
19. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
[TBL] [Abstract][Full Text] [Related]
20. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]